Log in

BioLife Solutions Stock Forecast, Price & News

+2.91 (+8.82 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $35.91
50-Day Range
MA: $30.54
52-Week Range
Now: $35.91
Volume197,900 shs
Average Volume268,488 shs
Market Capitalization$1.18 billion
P/E RatioN/A
Dividend YieldN/A
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Read More
BioLife Solutions logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.90 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:BLFS



Sales & Book Value

Annual Sales$27.37 million
Cash Flow$0.22 per share
Book Value$5.71 per share


Net Income$-1,660,000.00


Market Cap$1.18 billion
Next Earnings Date3/10/2021 (Estimated)
OptionableNot Optionable
+2.91 (+8.82 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BLFS News and Ratings via Email

Sign-up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BioLife Solutions (NASDAQ:BLFS) Frequently Asked Questions

How has BioLife Solutions' stock been impacted by COVID-19?

BioLife Solutions' stock was trading at $12.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BLFS stock has increased by 193.1% and is now trading at $35.91.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of BioLife Solutions?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioLife Solutions in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BioLife Solutions
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than BioLife Solutions?

Wall Street analysts have given BioLife Solutions a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BioLife Solutions wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is BioLife Solutions' next earnings date?

BioLife Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for BioLife Solutions

How were BioLife Solutions' earnings last quarter?

BioLife Solutions, Inc. (NASDAQ:BLFS) issued its quarterly earnings results on Wednesday, March, 11th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.02) by $0.04. The medical equipment provider had revenue of $8.30 million for the quarter, compared to analyst estimates of $8.72 million. BioLife Solutions had a return on equity of 0.53% and a net margin of 12.67%.
View BioLife Solutions' earnings history

What price target have analysts set for BLFS?

10 analysts have issued 1-year price targets for BioLife Solutions' shares. Their forecasts range from $17.00 to $40.00. On average, they expect BioLife Solutions' stock price to reach $30.22 in the next year. This suggests that the stock has a possible downside of 15.8%.
View analysts' price targets for BioLife Solutions

Who are some of BioLife Solutions' key competitors?

What other stocks do shareholders of BioLife Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioLife Solutions investors own include Canopy Growth (CGC), Micron Technology (MU), AbbVie (ABBV), Cara Therapeutics (CARA), Gilead Sciences (GILD), Pfizer (PFE), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Twilio (TWLO) and Verastem (VSTM).

Who are BioLife Solutions' key executives?

BioLife Solutions' management team includes the following people:
  • Mr. Michael P. Rice, Pres, CEO & Director (Age 57, Pay $649.25k)
  • Mr. Roderick de Greef, CFO, COO & Sec. (Age 60, Pay $447.78k)
  • Dr. Aby J. Mathew, Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer (Age 48, Pay $466.97k)
  • Mr. Todd Berard, Chief Marketing Officer (Age 51)
  • Mr. Marcus Schulz, VP of Global Sales (Age 42)
  • Ms. Karen Foster, Chief Quality Officer (Age 60)

What is BioLife Solutions' stock symbol?

BioLife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

Who are BioLife Solutions' major shareholders?

BioLife Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include Wasatch Advisors Inc. (5.37%), BlackRock Inc. (3.47%), Royce & Associates LP (2.64%), Gagnon Securities LLC (1.27%), Sentinel Pension Advisors Inc. (0.80%) and State Street Corp (0.64%). Company insiders that own BioLife Solutions stock include Aby J Mathew, Andrew G Hinson, Casdin Partners Master Fund, L, Greef Roderick De, James Mathers, Johan Wedell-Wedellsborg, Joseph C Schick, Karen A Foster, Marcus Schulz, Michael Rice, Raymond W Cohen, Thomas Girschweiler, Todd Berard and Walter Villiger.
View institutional ownership trends for BioLife Solutions

Which institutional investors are selling BioLife Solutions stock?

BLFS stock was sold by a variety of institutional investors in the last quarter, including Sentinel Pension Advisors Inc., Cadence Capital Management LLC, Candriam Luxembourg S.C.A., Mesirow Financial Investment Management Inc., Signaturefd LLC, Cowen Prime Services LLC, Acuitas Investments LLC, and Acuitas Investments LLC. Company insiders that have sold BioLife Solutions company stock in the last year include Aby J Mathew, Greef Roderick De, James Mathers, Karen A Foster, Marcus Schulz, Michael Rice, Raymond W Cohen, Thomas Girschweiler, Todd Berard, and Walter Villiger.
View insider buying and selling activity for BioLife Solutions

Which institutional investors are buying BioLife Solutions stock?

BLFS stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., BlackRock Inc., Gagnon Securities LLC, Ziegler Capital Management LLC, Royce & Associates LP, Iron Triangle Partners LP, Charles Schwab Investment Management Inc., and Gagnon Advisors LLC.
View insider buying and selling activity for BioLife Solutions

How do I buy shares of BioLife Solutions?

Shares of BLFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioLife Solutions' stock price today?

One share of BLFS stock can currently be purchased for approximately $35.91.

How big of a company is BioLife Solutions?

BioLife Solutions has a market capitalization of $1.18 billion and generates $27.37 million in revenue each year. The medical equipment provider earns $-1,660,000.00 in net income (profit) each year or $0.08 on an earnings per share basis. BioLife Solutions employs 54 workers across the globe.

What is BioLife Solutions' official website?

The official website for BioLife Solutions is www.biolifesolutions.com.

How can I contact BioLife Solutions?

BioLife Solutions' mailing address is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. The medical equipment provider can be reached via phone at 425-402-1400 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.